查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532976

聚合物添加剂市场－2024年至2029年预测

Polymer Excipients Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计在预测期（2024-2029年）聚合物添加剂市场将以4.27%的复合年增长率成长。

聚合物添加剂市场可以定义为源自合成和天然聚合物的药物製剂成分的快速开拓领域。药物传递系统中的重要赋形剂可提高药物的稳定性和功效。

聚合物赋形剂在药物传递系统中的灵活用途包括控制释放製剂、封装、锭剂包衣以及与生技药品缀合以提高溶解度。它也用于生产药用油墨、製备着色剂和颜料、化妆品以及高级伤口护理。这是由于对药物输送新技术的需求不断增长、疾病发病率上升以及患者依从性提高而推动的。

  • 聚合物添加剂市场呈上升趋势，背后有几个原因。 TSWI 将世界对新型药物输送系统的需求视为主要成长要素之一。随着製药业先进治疗方法的增加，对药物稳定性、生物有效性和功效方面性能更好的辅料的需求也不断增加。涉及控制释放系统、封装和与生技药品缀合的聚合物添加剂对于建构最先进的药物传递系统至关重要。这种需求是由慢性病的增加和提高患者依从性的需求所驱动的。
  • 促进市场成长的另一个因素是全球学名药的使用不断增加。市场正在见证学名药的进入，其中许多仿製药以前由于专利保护失效而成为品牌药的专属领域。因此，辅料支持学名药的品质、安全性和有效性。在这方面，聚合物赋形剂是重要的製剂成分，可增强化学和物理稳定性，从而增强学名药中所含治疗剂的功效。预计这一趋势将持续下去，对聚合物添加剂的需求将进一步增加，刺激聚合物添加剂市场的成长。

聚合物添加剂细分市场分析：

  • 聚乙烯吡咯烷酮产业将是预测期内成长最快的产业。

在所有聚合物添加剂中，聚乙烯吡咯烷酮（PVP）领域预计将成为预测期内特定市场中成长最快的领域。这是由于 PVP 在製药业中的使用越来越多，因为它具有相当专业的用途和特性。聚维酮（PVP）是一种合成聚合物，被认为是各种製剂中的重要赋形剂。易于人体吸收、溶解性、成膜性和渗透性等特性使其成为业界流行的添加剂。

PVP 常用于生产锭剂、胶囊、糖浆、灭菌剂、消毒剂和注射剂。它们在药物製剂中充当粘合剂、崩坏、增溶剂和稳定剂，并作为提高药物稳定性、生物有效性和功效的重要佐剂。

近年来，由于慢性病等健康併发症以及药物输送系统的技术进步，对 PVP 的需求增加。随着製药工业的进步以及更多特异性和有效药物的开发，对用于提高药物效率的赋形剂的需求增加。随着循环系统领域患者服务的普遍化以及对更复杂和个人化的慢性疾病管理方法的需求，适应各种类型药物配方的PVP将满足这些未来的需求。生物製药製造和 COVID-19 疫苗开发等新趋势也创造了对 PVP 的需求。在这次大流行期间，辅料在此类基本药物的配方和製造中的作用变得更加重要，导致市场大幅成长。

  • 粘合剂市场似乎是预测期内成长最快的细分市场。

从上述分析可以得出结论，在预测期内，粘合剂部分可能是全球聚合物添加剂市场中成长最快的。这可能与用于改善药品物理和化学性质的粘合剂市场规模不断增长有关。聚合物添加剂属于粘合剂类别，用于製备固态剂型，包括锭剂和胶囊。粘合剂赋予配方弹性、拉伸强度和黏合成分，并有助于在储存和运输过程中保持其黏合和品质。也就是说，粘合剂可以溶液的形式或粉末的形式用于直接压片以用于特定的药物製剂。

由于慢性疾病的增加和药物输送方法的改进，粘合剂在製药行业中的使用增加。现代製药工业的特点是生产高度专业化的药物，需要有效的辅料来进一步提高其性能。透过改善配方的物理和化学性能，粘合剂可以有效地满足这种增加的需求。

生物製药领域的趋势和对 COVID-19 疫苗的需求正在推动粘合剂消费的增加。 COVID-19 危机的重点是药物配方和市场开拓中使用的辅料，推动了市场的重大发展。

  • 预计亚太地区将在预测期内主导聚合物添加剂市场。

由于几个关键因素，预计亚太地区将在预测期内主导聚合物添加剂市场。其主要原因是亚太地区正在不断开拓的医药市场对聚合物添加剂的需求不断增加。如果我们看一下中国和印度的案例，就会发现慢性病的增加、人口老化和医疗保健机会的增加正在改变药物生产和消费中药物提取的梯度。随着药品製造业的发展，药物配方中必不可少的聚合物添加剂的使用也不断发展。

该地区对学名药的需求呈现高速成长，推动了聚合物添加剂市场的发展。当今的学名药製造商主要依靠赋形剂来确保其产品安全有效。聚合物赋形剂也因其在提高学名药的稳定性和生物有效性方面的优势而在这个庞大的新兴市场中获得认可。

亚太地区个人化药物治疗的日益增长趋势以及新型药物传输系统的进步正在推动聚合物添加剂市场的发展。由于其配方组成的灵活性，聚合物添加剂有潜力满足该地区现有和新兴市场的需求。

此外，亚太地区生物製药产业的成长和 COVID-19 疫苗的发明也增加了辅料在救命药物生产中的使用。随着生产商扩大他们的研究兴趣以满足不断增长的市场，这有助于为聚合物添加剂市场带来一些改进。由于这些因素，由于製药业的快速成长、学名药、个人化药物的兴起以及新药物输送系统的进步，亚太地区在预测期内引领聚合物赋形剂市场。

聚合物添加剂市场细分与分析如下：

依产品类型

  • 聚乙烯吡咯烷酮
  • 聚乙二醇
  • 淀粉
  • 结晶纤维素（MCC）
  • 乙基和甲基纤维素
  • 羟丙基甲基纤维素（HPMC）
  • 其他的

按用途

  • 粘合剂
  • 黏度调节剂
  • 涂层
  • 香味
  • 防腐剂
  • 色素
  • 甜味剂
  • 其他的

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家
  • 中东/非洲
  • 沙乌地阿拉伯
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东/非洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 台湾
  • 泰国
  • 印尼
  • 其他亚太地区

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
    • 不断发展的製药业
    • 涂料应用对聚合物添加剂的需求增加
  • 市场限制因素
    • 监管机构的严格规定
    • 考虑满足产品品质要求
    • 来自替代品的威胁
  • 波特五力分析
  • 产业价值链分析

第五章聚合物添加剂市场：依产品类型

  • 介绍
  • 聚乙烯吡咯烷酮
  • 聚乙二醇
  • 淀粉
  • 结晶纤维素（MCC）
  • 乙基和甲基纤维素
  • 羟丙基甲基纤维素（HPMC）
  • 其他的

第六章聚合物添加剂市场：依应用分类

  • 介绍
  • 粘合剂
  • 黏度调节剂
  • 涂层
  • 香味
  • 防腐剂
  • 着色剂
  • 甜味剂
  • 其他的

第七章聚合物添加剂市场：按地区

  • 世界概况
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东/非洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他亚太地区

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • ABITEC
  • ADM
  • Ashland
  • BASF SE
  • Cargill, Incorporated.
  • Colorcon
  • Croda International Plc
  • DFE Pharma
  • Dow
  • DuPont
  • Eastman Chemical Company
  • Evonik Industries AG
  • FINAR LIMITED
  • JRS PHARMA
  • Kerry Inc.
  • Roquette Freres
  • The Lubrizol Corporation
简介目录
Product Code: KSI061616983

The polymer excipients market is expected to grow at a CAGR of 4.27% during the forecast period (2024-2029).

The polymer excipients market can be defined as the rapidly developing field of components for pharmaceutical formulations originating from synthetic and natural polymers. The following are some of the excipients that are important in drug delivery systems; they improve the stability and efficacy of pharmaceutical products.

The flexible use of polymer excipients in drug delivery systems includes controlled release formulations, encapsulation, coating of tablets, and conjugation to biologics to improve solubility. They are also employed in the production of pharmaceutical inks, the preparation of colorants and pigments, cosmetics, and advanced wound care items. This is due to the enhanced need for new technologies in drug delivery, the rising incidence of diseases, and strict patient compliance.

  • The polymer excipients market is on an upward trend and there are several reasons that have attributed to the above trend. TSWI has identified one of the large growth factors as being the global need for new drug delivery systems. With the increase of advanced therapies in the pharmaceutical industry, so is the requirement for excipients with better performance in stability, bioavailability, and effectiveness of the drugs. Polymer excipients that are involved in the controlled release systems, encapsulation, and conjugation to the biologics are critical to incorporate in creating state-of-the-art drug delivery systems. This need is heightened by the increasing incidence of chronic ailments and the necessity to enhance adherence among patients.
  • Another avenue for expanding the firm's growth is the increasing use of generic medicines globally. The market is witnessing the entry of generics, many of which were earlier solely in the domain of branded drugs due to the expiry of patent protection. As such, excipients are the backbone of generic drugs' quality, safety, and efficacy. In this regard, polymer excipients are significant formulating components that can enhance the chemical and physical stability and, therefore, the efficacy of the therapeutic agents contained in generic products. It is believed that this trend will persist in future years, and the need for polymer excipients will be even higher, stimulating the polymer excipients market's growth.

POLYMER EXCIPIENTS MARKET SEGMENT ANALYSIS:

  • The Polyvinylpyrrolidone segment will likely be the fastest-growing segment during the forecast period.

Out of all the polymer excipients, the polyvinylpyrrolidone (PVP) segment is predicted to be the fastest-growing segment in the identified market for the duration of the forecast year. This can be attributed to the rise in the usage of PVP in the pharmaceutical industry because of its fairly special uses and characteristics. Povidone, which is identified as PVP, is a synthetic polymer that is regarded as an essential excipient in different types of formulations. Ease of absorption into the body, as well as such qualities as solubility and film-forming properties and the organism's impermeability - all these make it a popular additive in the industry.

PVP is usually used in the production of tablets, capsules, syrup, sterilization, disinfection, and injection. It functions as a binder, disintegrant, solubilizer, and stabilizer in drug formulations, thus acting as an important adjuvant in improving the stability, bioavailability, and effectiveness of pharmaceuticals.

The need for PVP has risen in recent years due to health complications such as chronic diseases and enhancements of techniques in drug delivery systems. With the progression of the pharmaceutical industry and the creation of more specific, effective medication the need for excipients rises as they play the role of improving drug efficiency. The generalization of patient services and the need for more sophisticated and individualized approaches in the management of chronic disease in the field of cardiovascular therapy allows PVP, which can be adapted to different types of drug formulations, to meet these future needs. The new tendencies, such as the biopharmaceuticals production and the COVID-19 vaccine development, also create demand for PVP. The role of excipients as ingredients in the formulation and manufacturing of such essential drugs has been more emphasized during this pandemic, and as a result, great achievements have been made on the market.

  • The Binders segment will likely be the fastest-growing segment during the forecast period.

Based on the above analysis, it can be concluded that the binders segment is likely to grow at the fastest rate in the global polymer excipients market over the forecasting period. This may be related to the rising market size for binders in the pharma, which is used to enhance the physical and chemical characteristics of drug products. Polymer excipients belong to the category of binders and are employed in the preparation of solid dosage forms including tablets and capsules. They assist in conveying elasticity, tensile strength, and a bonded composition to the formulation of the product to stay united and preserve its quality during storage or transport. This means that binders can be employed in solution form or as a powder for direct compaction for that specific formulation of drugs.

The rising usage of binders in the pharmaceutical industry is attributed to the rise in chronic ailments and improved drug delivery methods. The modern pharmaceutical industry is characterized by the production of highly specialized medicines, which require effective excipients to further boost their performance. By enhancing the physical and chemical characteristics of drug formulations, binders can effectively address this increasing demand.

The global trend of biopharmaceuticals and the need for the COVID-19 vaccine have caused increased binders consumption. The COVID-19 crisis has brought focus to excipients used in medicinal formulation and development, catalyzing significant market progress.

  • The Asia Pacific region will dominate the polymer excipients market during the forecast period.

The Asia Pacific region is expected to dominate the polymer excipients market during the forecast period, driven by several key factors. The primary reason is the increasing demand for polymer excipients in the continuously developing pharmaceutical market in the Asia Pacific area. From the cases of China and India, there has been a change in slope regarding the abstraction of pharmaceutical products through the production and consumption of the same due to the increased prevalence of chronic diseases, an aging population, and more access to healthcare. As the industry of manufacturing drugs evolves, the use of polymer excipients, which are crucial in drug formulation, also increases.

This region is experiencing high growth in the demand for generics, boosting the polymer excipients market. Today's generic drug makers depend mostly on excipients to make their products safe and effective for their users. Polymer excipients are well accepted in this large and emerging market because of their advantages in terms of improved stability and bioavailability of generic drugs.

The increasing trend of personalized medications, along with the advances in new drug delivery systems in the Asia Pacific region, have boosted the polymer excipients market. Because of their flexibility in the composition of drug formulations, polymer excipients have good potential for meeting the existing and emerging market needs in this region.

In addition, the growth of the biopharmaceutical sector and the invention of the COVID-19 vaccine in the Asia Pacific region have also increased the application of excipients in manufacturing life-saving medicines. This has helped bring several improvements in the polymer excipients market because producers expand their concerns on research to conform to the ever-growing market. Owing to these factors, the Asia Pacific area leads the polymer excipients market within the forecast period because of the fast-growing pharmaceutical industry, the increasing scope of generics, individualized medications, and the advancement of new drug delivery systems.

The polymer excipients market is segmented and analyzed as follows:

By Product Type

  • Polyvinylpyrrolidone
  • Polyethylene Glycol
  • Starch
  • Micro Crystalline Cellulose (MCC)
  • Ethyl and Methyl Cellulose
  • Hydroxypropyl Methylcellulose (HPMC)
  • Others

By Application

  • Binders
  • Viscosity Modifiers
  • Coatings
  • Flavors
  • Preservatives
  • Colorants
  • Sweeteners
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Middle East and Africa
  • Saudi Arabia
  • Saudi Arabia
  • United Arab Emirates
  • Rest of the Middle East and Africa
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
    • 4.1.1. Growing Pharmaceutical Industry
    • 4.1.2. Rising Demand for Polymer Excipients from Coatings Application
  • 4.2. Market Restraints
    • 4.2.1. Stringent Rules by Regulatory Bodies
    • 4.2.2. Concerns to Meet the Required Quality of Product
    • 4.2.3. Threats from Substitutes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. POLYMER EXCIPIENTS MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Polyvinylpyrrolidone
  • 5.3. Polyethylene Glycol
  • 5.4. Starch
  • 5.5. Micro Crystalline Cellulose (MCC)
  • 5.6. Ethyl and Methyl Cellulose
  • 5.7. Hydroxypropyl Methylcellulose (HPMC)
  • 5.8. Others

6. POLYMER EXCIPIENTS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Binders
  • 6.3. Viscosity Modifiers
  • 6.4. Coatings
  • 6.5. Flavors
  • 6.6. Preservatives
  • 6.7. Colorants
  • 6.8. Sweeteners
  • 6.9. Others

7. POLYMER EXCIPIENTS MARKET BY GEOGRAPHY

  • 7.1. Global Overview
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Rest of South America
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Rest of Europe
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. United Arab Emirates
    • 7.5.3. Rest of Middle East and Africa
  • 7.6. Asia-Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Rest of Asia-Pacific

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. ABITEC
  • 9.2. ADM
  • 9.3. Ashland
  • 9.4. BASF SE
  • 9.5. Cargill, Incorporated.
  • 9.6. Colorcon
  • 9.7. Croda International Plc
  • 9.8. DFE Pharma
  • 9.9. Dow
  • 9.10. DuPont
  • 9.11. Eastman Chemical Company
  • 9.12. Evonik Industries AG
  • 9.13. FINAR LIMITED
  • 9.14. JRS PHARMA
  • 9.15. Kerry Inc.
  • 9.16. Roquette Freres
  • 9.17. The Lubrizol Corporation